We are privileged to share the acknowledgment that APICES has received in the recent publication titled: “Impact on functionality of the paliperidone palmitate three-month formulation in patients with a recent diagnosis of schizophrenia: a real-world observational prospective study”, published in Expert Opinion on Pharmacotherapy, a study in which APICES has participated in study setup, project management, monitoring, and statistical analysis and provided editorial support for writing of the manuscript.
This means to all APICES team an extra motivation in order to give continuity to the implication we have in every project in which we collaborate. From APICES, we are pride because of the recognition of our work, and we want to thank Janssen Cilag for the opportunity they have given to APICES to appear in the acknowledgments section of the manuscript, and congratulate them and all the investigators for their project success.
This study assesses the impact of paliperidone palmitate three-month formulation on functionality in patients recently diagnosed with schizophrenia and also clinical stability, patient and caregiver satisfaction, and tolerability.
You can find the publication in the following link: